Skip to main content
Fig. 2 | BMC Medical Genomics

Fig. 2

From: An integrated analysis of public genomic data unveils a possible functional mechanism of psoriasis risk via a long-range ERRFI1 enhancer

Fig. 2

The eRNA-based quantified activity of enhancers. The “Percentage of Expression” for each cell type refers to how much of the total expression (normalized CAGE counts from all cells) the enhancer emits for each cell type. a The top 10 cells highly expressing eRNA from a CAGE-defined enhancer (hg19: chr1: 8,257,762-8,258,040) in which rs72635708 is located. b The top 7 cells highly expressing eRNA from a CAGE-defined enhancer (hg19: chr11: 64,140,304-64,140,795) in which rs11231770 is located

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us